• Je něco špatně v tomto záznamu ?

Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire

S. Kennon, R. Styra, N. Bonaros, L. Stastny, M. Romano, T. Lefèvre, C. Di Mario, P. Stefàno, FL. Ribichini, D. Himbert, M. Urena-Alcazar, J. Salgado-Fernandez, JJ. Cuenca Castillo, B. Garcia, C. Deutsch, L. Sykorova, J. Kurucova, M. Thoenes, C....

. 2021 ; 8 (2) : . [pub] -

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012033

BACKGROUND: The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) is a validated instrument for assessing quality of life (QoL) in patients with severe aortic stenosis (AS). In this study, we evaluated health status outcomes, based on the TASQ, in patients with severe AS undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). METHODS: The TASQ registry was a prospective observational registry. Patients with severe AS from nine centres in Europe and one in Canada underwent either SAVR or transfemoral TAVR. Patients completed the TASQ, Kansas City Cardiomyopathy Questionnaire and Short Form-12 V.2 prior to the intervention, predischarge, and at 30-day and 3-month follow-ups. Primary end point was the TASQ score. RESULTS: In both the TAVR (n=137) and SAVR (n=137) cohorts, significant increases were observed in all three scores. The overall TASQ score improved as did all but one of the individual domains at 3 months after the intervention (p<0.001). TASQ health expectations were the only domain which worsened (p<0.001). Across TASQ subscores, significant changes were evident from the time of discharge in the TAVR and 30-day follow-up in the SAVR cohort. In a categorical analysis of the TASQ, 39.7% of the TAVR group and 35.0% of the SAVR group had a substantially improved health status at 3 months compared with baseline. CONCLUSIONS: The TASQ captured changes in QoL among patients with severe AS who were treated with TAVR or SAVR. QoL improved substantially after either intervention, as indicated by changes in the TASQ overall score at 3 months. TRIAL REGISTRATION NUMBER: NCT03186339.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012033
003      
CZ-PrNML
005      
20220506131301.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/openhrt-2021-001821 $2 doi
035    __
$a (PubMed)34810276
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kennon, Simon $u Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, UK
245    10
$a Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire / $c S. Kennon, R. Styra, N. Bonaros, L. Stastny, M. Romano, T. Lefèvre, C. Di Mario, P. Stefàno, FL. Ribichini, D. Himbert, M. Urena-Alcazar, J. Salgado-Fernandez, JJ. Cuenca Castillo, B. Garcia, C. Deutsch, L. Sykorova, J. Kurucova, M. Thoenes, C. Lüske, P. Bramlage, D. Frank
520    9_
$a BACKGROUND: The Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) is a validated instrument for assessing quality of life (QoL) in patients with severe aortic stenosis (AS). In this study, we evaluated health status outcomes, based on the TASQ, in patients with severe AS undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). METHODS: The TASQ registry was a prospective observational registry. Patients with severe AS from nine centres in Europe and one in Canada underwent either SAVR or transfemoral TAVR. Patients completed the TASQ, Kansas City Cardiomyopathy Questionnaire and Short Form-12 V.2 prior to the intervention, predischarge, and at 30-day and 3-month follow-ups. Primary end point was the TASQ score. RESULTS: In both the TAVR (n=137) and SAVR (n=137) cohorts, significant increases were observed in all three scores. The overall TASQ score improved as did all but one of the individual domains at 3 months after the intervention (p<0.001). TASQ health expectations were the only domain which worsened (p<0.001). Across TASQ subscores, significant changes were evident from the time of discharge in the TAVR and 30-day follow-up in the SAVR cohort. In a categorical analysis of the TASQ, 39.7% of the TAVR group and 35.0% of the SAVR group had a substantially improved health status at 3 months compared with baseline. CONCLUSIONS: The TASQ captured changes in QoL among patients with severe AS who were treated with TAVR or SAVR. QoL improved substantially after either intervention, as indicated by changes in the TASQ overall score at 3 months. TRIAL REGISTRATION NUMBER: NCT03186339.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a aortální chlopeň $x chirurgie $7 D001021
650    _2
$a aortální stenóza $x epidemiologie $x psychologie $x chirurgie $7 D001024
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    12
$a zdravotní stav $7 D006304
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a morbidita $x trendy $7 D009017
650    _2
$a pooperační období $7 D011184
650    _2
$a prospektivní studie $7 D011446
650    12
$a kvalita života $7 D011788
650    12
$a průzkumy a dotazníky $7 D011795
650    _2
$a transkatetrální implantace aortální chlopně $x psychologie $7 D065467
651    _2
$a Kanada $x epidemiologie $7 D002170
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Styra, Rima $u Department of Psychiatry, University Health Network, Toronto, Ontario, Canada
700    1_
$a Bonaros, Nikolaos $u Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria $1 https://orcid.org/0000000276565812
700    1_
$a Stastny, Lukas $u Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria
700    1_
$a Romano, Mauro $u Department of Thoracic and Cardiovascular Surgery, Hopital Prive Jacques Cartier, Massy, France
700    1_
$a Lefèvre, Thierry $u Institut Jacques Cartier, Massy, France
700    1_
$a Di Mario, Carlo $u Department of Structural Interventional Cardiology, Department of Cardiac Surgery, Careggi University Hospital, Florence, Italy
700    1_
$a Stefàno, Pierluigi $u Department of Structural Interventional Cardiology, Department of Cardiac Surgery, Careggi University Hospital, Florence, Italy
700    1_
$a Ribichini, Flavio Luciano $u Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
700    1_
$a Himbert, Dominique $u Department of Cardiology, Bichat-Claude Bernard Hospital, Paris, France
700    1_
$a Urena-Alcazar, Marina $u Department of Cardiology, Bichat-Claude Bernard Hospital, Paris, France
700    1_
$a Salgado-Fernandez, Jorge $u Department of Cardiology, Department of Cardiovascular Surgery, Hospital Juan Canalejo, Coruna, Spain
700    1_
$a Cuenca Castillo, Jose Joaquin $u Department of Cardiology, Department of Cardiovascular Surgery, Hospital Juan Canalejo, Coruna, Spain
700    1_
$a Garcia, Bruno $u Department of Cardiology, Hospital Vall d'Hebron, CIBER CV, Barcelona, Spain
700    1_
$a Deutsch, Cornelia $u Clinical Studies and Registries, Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
700    1_
$a Sykorova, Lenka $u Medical Affairs, Edwards Lifesciences, Prague, Czech Republic
700    1_
$a Kurucova, Jana $u Medical Affairs, Edwards Lifesciences, Prague, Czech Republic
700    1_
$a Thoenes, Martin $u Medical Affairs, Edwards Lifesciences, Nyon, Switzerland
700    1_
$a Lüske, Claudia $u Clinical Studies and Registries, Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
700    1_
$a Bramlage, Peter $u Clinical Studies and Registries, Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany $1 https://orcid.org/0000000349702110
700    1_
$a Frank, Derk $u Department of Internal Medicine III (Cardiology, Angiology and Critical Care), Germany and DZHK (German Centre for Cardiovascular Research), Kiel, Germany derk.frank@uksh.de $1 https://orcid.org/000000017561075X
773    0_
$w MED00186378 $t Open heart $x 2053-3624 $g Roč. 8, č. 2 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34810276 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131253 $b ABA008
999    __
$a ok $b bmc $g 1789571 $s 1163234
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 8 $c 2 $e - $i 2053-3624 $m Open heart $n Open Heart $x MED00186378
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace